Klee Justin B.

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 32% 68% 82%
Transactions
14 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Klee Justin B.'s trades of Amylyx Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
33.60
Quantity 100,000
Value US$3,360,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-14 2026-09-10
S Sale
9,486 +2.7%
406.43
US$1,727,238 		9,486 +2.7% 406.43 US$1,727,238
2026-09-14 2026-09-10
S Sale
41,534 +10.4%
32.19
US$2,106,291 		41,534 +10.4% 32.19 US$2,106,291
2026-09-11 2026-09-10
PrS Proposed sale
44,738
291.39
US$3,947,056 		44,738 291.39 US$3,947,056
2026-03-04 2026-03-02
S Sale
29,282 -0.9%
14.47
US$423,760 		29,282 -0.9% 14.47 US$423,760
2026-03-02 2026-03-02
PrS Proposed sale
29,282
14.47
US$423,760 		29,282 14.47 US$423,760
2026-02-04 2026-02-02
S Sale
15,500 -0.5%
14.69
US$227,618 		15,500 -0.5% 14.69 US$227,618
2026-02-02 2026-02-02
PrS Proposed sale
15,500
14.68
US$227,617 		15,500 14.68 US$227,617
2026-01-20 2026-01-16
S Sale
1,995 -0.1%
13.89
US$27,701 		1,995 -0.1% 13.89 US$27,701
2026-01-16 2026-01-16
PrS Proposed sale
1,995
13.52
US$26,972 		1,995 13.52 US$26,972
2026-01-20 2026-01-15
S Sale
136,193 -3.9%
13.58
US$1,849,869 		136,193 -3.9% 13.58 US$1,849,869
2026-01-15 2026-01-15
PrS Proposed sale
136,193
14.07
US$1,916,236 		136,193 14.07 US$1,916,236
2026-01-08 2026-01-06
S Sale
7,715 -0.2%
11.09
US$85,589 		7,715 -0.2% 11.09 US$85,589
2026-01-06 2026-01-06
PrS Proposed sale
7,715
11.09
US$85,590 		7,715 11.09 US$85,590
2025-10-02 2025-09-30
S Sale
200 -0.0%
15.01
US$3,002 		200 -0.0% 15.01 US$3,002
2025-10-02 2025-09-30
S Sale
29,775 -0.9%
14.37
US$427,950 		29,775 -0.9% 14.37 US$427,950
2025-04-02 2025-03-31
S Sale
21,490 -0.6%
3.46
US$74,454 		21,490 -0.6% 3.46 US$74,454
2025-03-05 2025-03-03
S Sale
4,595 -0.1%
3.15
US$14,483 		4,595 -0.1% 3.15 US$14,483
2025-02-05 2025-02-03
S Sale
11,855 -0.4%
3.47
US$41,104 		11,855 -0.4% 3.47 US$41,104
2025-01-08 2025-01-06
S Sale
7,471 -0.2%
4.04
US$30,202 		7,471 -0.2% 4.04 US$30,202
2024-10-02 2024-09-30
S Sale
18,589 -0.6%
3.20
US$59,429 		18,589 -0.6% 3.20 US$59,429
2024-03-07 2024-03-05
S Sale
4,135 -0.1%
18.73
US$77,440 		4,135 -0.1% 18.73 US$77,440
2024-01-11 2024-01-09
S Sale
5,841 -0.2%
16.33
US$95,372 		5,841 -0.2% 16.33 US$95,372
2023-03-20 2023-03-16
PlS Planned sale
3,445 -0.1%
32.48
US$111,877 		3,445 -0.1% 32.48 US$111,877
2023-03-20 2023-03-16
PlS Planned sale
96,555 -3.3%
31.84
US$3,074,359 		96,555 -3.3% 31.84 US$3,074,359
2023-03-16 2023-03-16
PrS Proposed sale
100,000
33.60
US$3,360,000 		100,000 33.60 US$3,360,000